SidaGhanaV1, PascalFrancis, Curation, bibRecord, 000079

Deferred donor care in a regional hospital blood center in Ghana

Identifieur interne : 000079 ( PascalFrancis/Curation ); précédent : 000078; suivant : 000080

Deferred donor care in a regional hospital blood center in Ghana

Auteurs : Jean-Pierre Allain [Royaume-Uni, Ghana] ; Ohene Opare-Sem ; Francis Sarkodie ; Rabiatu Rahman ; Shirley Owusu-Ofori

Source :

Transfusion : (Philadelphia, PA) [ 0041-1132 ] ; 2009.

RBID : Pascal:09-0186728

Descripteurs français

Pascal (Inist)
- Donneur limite, Transfusion.

English descriptors

KwdEn :
- Suboptimal donor, Transfusion.

Abstract

BACKGROUND: In sub-Saharan Africa, the viral marker burden in blood donor populations ranges between 10 and 30 percent. Deferred donors constitute a rare population of asymptomatic human immunodeficiency virus (HIV)- and hepatitis B virus (HBV)-infected individuals with high likelihood of long survival if cared for. Deferred donor care provides an opportunity for a public health impact on highly pathogenic infections. STUDY DESIGN AND METHODS: Between 2004 and 2007, all candidate donors deferred before donation for reactivity of anti-HIV, hepatitis C virus antibody (anti-HCV), and hepatitis B virus surface antigen (HBsAg) rapid tests were informed and referred to a donor care program consisting of test confirmation, information, counseling, and potential referral for follow-up and therapy. Dedicated trained nurses supervised the program including alanine aminotransferase (ALT) level testing to identify liver disease. RESULTS: In a 4-year period 51,100 donors were screened and 5778, 1578, and 227 candidate donors were deferred for reactivity to HBV, HIV, or HCV serologic markers, respectively. The rates of entry into the donor care program were 48, 14.3, and 22 percent of deferred donors, respectively. A total of 83 of 210 HBsAg-positive donors with elevated ALT levels were referred and 66 received antiviral treatment. A total of 89 of 516 confirmed anti-HIV-positive donors were referred to the hospital acquired immune deficiency syndrome clinic for follow-up. CONCLUSIONS: With little additional expense, the deferred donor care program identified asymptomatic infections with high odds of benefiting from monitoring and therapy. In the local circumstances, this public health-limited but definite impact was permitted by the rapid-test predonation screening, and this impact could be increased if more resources were available.

A01	`01`	`1`		`@0 0041-1132`
A02	`01`			`@0 TRANAT`
A03		`1`		`@0 Transfusion : (Phila., PA)`
A05				`@2 49`
A06				`@2 4`
A08	`01`	`1`	`ENG`	`@1 Deferred donor care in a regional hospital blood center in Ghana`
A11	`01`	`1`		`@1 ALLAIN (Jean-Pierre)`
A11	`02`	`1`		`@1 OPARE-SEM (Ohene)`
A11	`03`	`1`		`@1 SARKODIE (Francis)`
A11	`04`	`1`		`@1 RAHMAN (Rabiatu)`
A11	`05`	`1`		`@1 OWUSU-OFORI (Shirley)`
A14	`01`			`@1 Division of Transfusion Medicine, Department of Haematology, University of Cambridge @2 Cambridge @3 GBR`
A14	`02`			`@1 Department of Medicine, and the Transfusion Medicine Unit, Komfo Anokye Teaching Hospital @2 Kumasi @3 GHA`
A20				`@1 669-675`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 10224 @5 354000184908710110`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 14 ref.`
A47	`01`	`1`		`@0 09-0186728`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Transfusion : (Philadelphia, PA)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 BACKGROUND: In sub-Saharan Africa, the viral marker burden in blood donor populations ranges between 10 and 30 percent. Deferred donors constitute a rare population of asymptomatic human immunodeficiency virus (HIV)- and hepatitis B virus (HBV)-infected individuals with high likelihood of long survival if cared for. Deferred donor care provides an opportunity for a public health impact on highly pathogenic infections. STUDY DESIGN AND METHODS: Between 2004 and 2007, all candidate donors deferred before donation for reactivity of anti-HIV, hepatitis C virus antibody (anti-HCV), and hepatitis B virus surface antigen (HBsAg) rapid tests were informed and referred to a donor care program consisting of test confirmation, information, counseling, and potential referral for follow-up and therapy. Dedicated trained nurses supervised the program including alanine aminotransferase (ALT) level testing to identify liver disease. RESULTS: In a 4-year period 51,100 donors were screened and 5778, 1578, and 227 candidate donors were deferred for reactivity to HBV, HIV, or HCV serologic markers, respectively. The rates of entry into the donor care program were 48, 14.3, and 22 percent of deferred donors, respectively. A total of 83 of 210 HBsAg-positive donors with elevated ALT levels were referred and 66 received antiviral treatment. A total of 89 of 516 confirmed anti-HIV-positive donors were referred to the hospital acquired immune deficiency syndrome clinic for follow-up. CONCLUSIONS: With little additional expense, the deferred donor care program identified asymptomatic infections with high odds of benefiting from monitoring and therapy. In the local circumstances, this public health-limited but definite impact was permitted by the rapid-test predonation screening, and this impact could be increased if more resources were available.
C02	`01`	`X`		`@0 002B27D01`
C02	`02`	`X`		`@0 002B27C`
C03	`01`	`X`	`FRE`	`@0 Donneur limite @5 09`
C03	`01`	`X`	`ENG`	`@0 Suboptimal donor @5 09`
C03	`01`	`X`	`SPA`	`@0 Donante marginal @5 09`
C03	`02`	`X`	`FRE`	`@0 Transfusion @5 10`
C03	`02`	`X`	`ENG`	`@0 Transfusion @5 10`
C03	`02`	`X`	`SPA`	`@0 Transfusión @5 10`
N21				`@1 138`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000058

Links to Exploration step

Pascal:09-0186728

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Deferred donor care in a regional hospital blood center in Ghana</title>
<author><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Transfusion Medicine, Department of Haematology, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medicine, and the Transfusion Medicine Unit, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
</inist:fA14>
<country>Ghana</country>
</affiliation>
</author>
<author><name sortKey="Opare Sem, Ohene" sort="Opare Sem, Ohene" uniqKey="Opare Sem O" first="Ohene" last="Opare-Sem">Ohene Opare-Sem</name>
</author>
<author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name>
</author>
<author><name sortKey="Rahman, Rabiatu" sort="Rahman, Rabiatu" uniqKey="Rahman R" first="Rabiatu" last="Rahman">Rabiatu Rahman</name>
</author>
<author><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0186728</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0186728 INIST</idno>
<idno type="RBID">Pascal:09-0186728</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000058</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000079</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Deferred donor care in a regional hospital blood center in Ghana</title>
<author><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Transfusion Medicine, Department of Haematology, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medicine, and the Transfusion Medicine Unit, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
</inist:fA14>
<country>Ghana</country>
</affiliation>
</author>
<author><name sortKey="Opare Sem, Ohene" sort="Opare Sem, Ohene" uniqKey="Opare Sem O" first="Ohene" last="Opare-Sem">Ohene Opare-Sem</name>
</author>
<author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name>
</author>
<author><name sortKey="Rahman, Rabiatu" sort="Rahman, Rabiatu" uniqKey="Rahman R" first="Rabiatu" last="Rahman">Rabiatu Rahman</name>
</author>
<author><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name>
</author>
</analytic>
<series><title level="j" type="main">Transfusion : (Philadelphia, PA)</title>
<title level="j" type="abbreviated">Transfusion : (Phila., PA)</title>
<idno type="ISSN">0041-1132</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Transfusion : (Philadelphia, PA)</title>
<title level="j" type="abbreviated">Transfusion : (Phila., PA)</title>
<idno type="ISSN">0041-1132</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Suboptimal donor</term>
<term>Transfusion</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Donneur limite</term>
<term>Transfusion</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: In sub-Saharan Africa, the viral marker burden in blood donor populations ranges between 10 and 30 percent. Deferred donors constitute a rare population of asymptomatic human immunodeficiency virus (HIV)- and hepatitis B virus (HBV)-infected individuals with high likelihood of long survival if cared for. Deferred donor care provides an opportunity for a public health impact on highly pathogenic infections. STUDY DESIGN AND METHODS: Between 2004 and 2007, all candidate donors deferred before donation for reactivity of anti-HIV, hepatitis C virus antibody (anti-HCV), and hepatitis B virus surface antigen (HBsAg) rapid tests were informed and referred to a donor care program consisting of test confirmation, information, counseling, and potential referral for follow-up and therapy. Dedicated trained nurses supervised the program including alanine aminotransferase (ALT) level testing to identify liver disease. RESULTS: In a 4-year period 51,100 donors were screened and 5778, 1578, and 227 candidate donors were deferred for reactivity to HBV, HIV, or HCV serologic markers, respectively. The rates of entry into the donor care program were 48, 14.3, and 22 percent of deferred donors, respectively. A total of 83 of 210 HBsAg-positive donors with elevated ALT levels were referred and 66 received antiviral treatment. A total of 89 of 516 confirmed anti-HIV-positive donors were referred to the hospital acquired immune deficiency syndrome clinic for follow-up. CONCLUSIONS: With little additional expense, the deferred donor care program identified asymptomatic infections with high odds of benefiting from monitoring and therapy. In the local circumstances, this public health-limited but definite impact was permitted by the rapid-test predonation screening, and this impact could be increased if more resources were available.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0041-1132</s0>
</fA01>
<fA02 i1="01"><s0>TRANAT</s0>
</fA02>
<fA03 i2="1"><s0>Transfusion : (Phila., PA)</s0>
</fA03>
<fA05><s2>49</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Deferred donor care in a regional hospital blood center in Ghana</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ALLAIN (Jean-Pierre)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>OPARE-SEM (Ohene)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SARKODIE (Francis)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>RAHMAN (Rabiatu)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>OWUSU-OFORI (Shirley)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Transfusion Medicine, Department of Haematology, University of Cambridge</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
</fA14>
<fA14 i1="02"><s1>Department of Medicine, and the Transfusion Medicine Unit, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
</fA14>
<fA20><s1>669-675</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>10224</s2>
<s5>354000184908710110</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>14 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0186728</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Transfusion : (Philadelphia, PA)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>BACKGROUND: In sub-Saharan Africa, the viral marker burden in blood donor populations ranges between 10 and 30 percent. Deferred donors constitute a rare population of asymptomatic human immunodeficiency virus (HIV)- and hepatitis B virus (HBV)-infected individuals with high likelihood of long survival if cared for. Deferred donor care provides an opportunity for a public health impact on highly pathogenic infections. STUDY DESIGN AND METHODS: Between 2004 and 2007, all candidate donors deferred before donation for reactivity of anti-HIV, hepatitis C virus antibody (anti-HCV), and hepatitis B virus surface antigen (HBsAg) rapid tests were informed and referred to a donor care program consisting of test confirmation, information, counseling, and potential referral for follow-up and therapy. Dedicated trained nurses supervised the program including alanine aminotransferase (ALT) level testing to identify liver disease. RESULTS: In a 4-year period 51,100 donors were screened and 5778, 1578, and 227 candidate donors were deferred for reactivity to HBV, HIV, or HCV serologic markers, respectively. The rates of entry into the donor care program were 48, 14.3, and 22 percent of deferred donors, respectively. A total of 83 of 210 HBsAg-positive donors with elevated ALT levels were referred and 66 received antiviral treatment. A total of 89 of 516 confirmed anti-HIV-positive donors were referred to the hospital acquired immune deficiency syndrome clinic for follow-up. CONCLUSIONS: With little additional expense, the deferred donor care program identified asymptomatic infections with high odds of benefiting from monitoring and therapy. In the local circumstances, this public health-limited but definite impact was permitted by the rapid-test predonation screening, and this impact could be increased if more resources were available.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B27D01</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B27C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Donneur limite</s0>
<s5>09</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Suboptimal donor</s0>
<s5>09</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Donante marginal</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Transfusion</s0>
<s5>10</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Transfusion</s0>
<s5>10</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Transfusión</s0>
<s5>10</s5>
</fC03>
<fN21><s1>138</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000079 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000079 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:09-0186728
   |texte=   Deferred donor care in a regional hospital blood center in Ghana
}}

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Deferred donor care in a regional hospital blood center in Ghana

Deferred donor care in a regional hospital blood center in Ghana

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri